## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li
Experience with long-term treatment with albumin-supplemented botulinum toxin type A
β Scribed by Bahram Mohammadi; Katja Kollewe; Maresa Wegener; Hans Bigalke; Reinhard Dengler
- Book ID
- 106207522
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 158 KB
- Volume
- 116
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We examined the impact of cervical dystonia (CD) and longβterm botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of longβterm treatment were obtained from 62 CD patients aged 31β66 years (med
## Abstract To evaluate the immunogenicity of botulinum toxin type A (BoNTA; BOTOX) in cervical dystonia (CD). Subjects diagnosed with CD for β₯1 year and previously naΓ―ve to BoNTs were treated with BoNTA in a prospective, openβlabel, multicenter study. Serum samples were analyzed for BoNTA neutrali